Technology
Health
2019 IPO

BridgeBio Pharma

766

$24.74
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.34 (-1.36%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell BBIO and other stocks, options, ETFs, and crypto commission-free!

About BBIO

BridgeBio Pharma, Inc. Common Stock, also called BridgeBio Pharma, is a pharma company. Read More The firm engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Frank McCormick, Philip Reilly and Neil Kumar on May 17, 2019 and is headquartered in Palo Alto, CA.

CEO
Neil Kumar
Employees
248
Headquarters
Palo Alto, California
Founded
2015
Market Cap
3.06B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.89M
High Today
$25.50
Low Today
$23.74
Open Price
$24.61
Volume
460.39K
52 Week High
$48.36
52 Week Low
$14.23

Collections

Technology
Health
2019 IPO
US
North America

BBIO Earnings

-$3.46
-$2.31
-$1.15
$0.00
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 5, Pre-Market

People Also Bought

Adaptive Biotechnologies

2,749

$28.13

+2.25%

Adaptive Biotechnologies

2,749

$28.13

+2.25%

Viking Therapeutics

51,331

$4.55

+4.60%

Precision BioSciences

6,203

$5.54

+5.12%

Health Catalyst

1,415

$27.19

-0.15%

You May Also Like

MARPS
XSHQ
SNP
ESGRP
QD
EXLS
RNG
DTF
DXR
MUDS
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy BBIO

Market Price$24.74
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell BBIO stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up